ARDX - Ardelyx, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ARDX (1437402)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
81 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-09-08
ARDXRosenbaum David P.Chief Development OfficerS - Sale$4.55-2,897558,839-1%-$13,181
2023-08-21
ARDXRodriguez SusanChief Commercial OfficerS - Sale$3.55-4,733348,687-1%-$16,811
2023-08-21
ARDXWilliams Laura AChief Medical OfficerS - Sale$3.55-2,591291,839-1%-$9,203
2023-08-21
ARDXRosenbaum David P.Chief Development OfficerS - Sale$3.55-3,783558,736-1%-$13,436
2023-08-21
ARDXRenz Justin ACFOS - Sale$3.55-2,884333,849-1%-$10,243
2023-08-21
ARDXRaab MichaelPres, CEOS - Sale$3.55-11,419901,600-1%-$40,558
2023-08-21
ARDXGrammer Elizabeth ASee RemarksS - Sale$3.55-2,392328,059-1%-$8,496
2023-08-21
ARDXFelsch Robert OraSee RemarksS - Sale$3.55-1,048115,110-1%-$3,722
2023-08-21
ARDXBlanks RobertSee RemarksS - Sale$3.55-2,846263,288-1%-$10,108
2023-06-27
ARDXWilliams Laura AChief Medical OfficerS - Sale$3.35-25,000294,430-8%-$83,633
D
2023-06-23
ARDXBlanks RobertSee RemarksS - Sale+OE$3.63-33,333266,134-11%-$121,042
2023-05-23
ARDXFelsch Robert OraSee RemarksS - Sale$3.65-1,046116,158-1%-$3,821
2023-05-23
ARDXRaab MichaelPres, CEOS - Sale$3.65-11,357913,019-1%-$41,489
2023-05-23
ARDXGrammer Elizabeth ASee RemarksS - Sale$3.65-2,384330,451-1%-$8,709
2023-05-23
ARDXBlanks RobertSee RemarksS - Sale$3.65-2,835266,134-1%-$10,357
2023-05-23
ARDXRenz Justin ACFOS - Sale$3.65-2,873336,733-1%-$10,496
2023-05-23
ARDXRodriguez SusanChief Commercial OfficerS - Sale$3.65-4,711353,420-1%-$17,210
2023-05-23
ARDXRosenbaum David P.Chief Development OfficerS - Sale$3.65-3,769562,519-1%-$13,769
2023-05-23
ARDXWilliams Laura AChief Medical OfficerS - Sale$3.65-2,583319,430-1%-$9,436
2023-03-29
ARDXRosenbaum David P.Chief Development OfficerS - Sale$4.63-3,000566,288-1%-$13,888
2023-02-21
ARDXRodriguez SusanChief Commercial OfficerS - Sale$3.00-5,586355,131-2%-$16,764
2023-02-21
ARDXWilliams Laura AChief Medical OfficerS - Sale$3.00-3,187319,013-1%-$9,564
2023-02-21
ARDXBlanks RobertSee RemarksS - Sale$3.00-3,394268,969-1%-$10,185
2023-02-21
ARDXGrammer Elizabeth ASee RemarksS - Sale$3.00-2,914332,925-1%-$8,745
2023-02-21
ARDXRaab MichaelPres, CEOS - Sale$3.00-13,449921,376-1%-$40,360
2023-02-21
ARDXFelsch Robert OraSee RemarksS - Sale$3.00-3,214114,204-3%-$9,645
2023-02-21
ARDXRenz Justin ACFOS - Sale$3.00-3,439336,606-1%-$10,320
2023-02-21
ARDXRosenbaum David P.Chief Development OfficerS - Sale$3.00-4,508566,288-1%-$13,529
2022-11-22
ARDXRosenbaum David P.Chief Development OfficerS - Sale$1.95-1,948467,4710%-$3,797
2022-11-22
ARDXGrammer Elizabeth ASee RemarksS - Sale$1.95-1,242257,8390%-$2,421
2022-11-22
ARDXRodriguez SusanChief Commercial OfficerS - Sale$1.95-3,456282,717-1%-$6,736
2022-11-22
ARDXRaab MichaelPres, CEOS - Sale$1.95-6,219684,825-1%-$12,120
2022-11-22
ARDXRenz Justin ACFOS - Sale$1.95-1,504262,045-1%-$2,931
2022-11-22
ARDXWilliams Laura AChief Medical OfficerS - Sale$1.95-1,241244,200-1%-$2,419
2022-11-22
ARDXBlanks RobertSee RemarksS - Sale$1.95-1,464194,363-1%-$2,853
2022-11-17
ARDXMott David MDirP - Purchase$1.76+567,0001,166,765+95%+$1,000,642
2022-10-05
ARDXBlanks RobertSee RemarksS - Sale$1.50-100,000195,827-34%-$150,000
2022-08-31
ARDXFelsch Robert OraSee RemarksP - Purchase$0.62+3,00091,418+3%+$1,856
2022-08-31
ARDXRosenbaum David P.Chief Development OfficerP - Purchase$0.62+3,000469,419+1%+$1,856
2022-09-01
ARDXRosenbaum David P.Chief Development OfficerS - Sale$0.92-3,000469,419-1%-$2,760
2022-08-31
ARDXRenz Justin ACFOP - Purchase$0.62+3,000263,549+1%+$1,856
2022-08-31
ARDXWilliams Laura AChief Medical OfficerP - Purchase$0.62+3,000245,441+1%+$1,856
2022-08-31
ARDXRaab MichaelPres, CEOP - Purchase$0.62+3,000691,0440%+$1,856
2022-08-31
ARDXGrammer Elizabeth ASee RemarksP - Purchase$0.62+3,000259,081+1%+$1,856
2022-08-26
ARDXBlanks RobertSee RemarksS - Sale$1.04-21,842295,827-7%-$22,713
2022-08-22
ARDXRodriguez SusanChief Commercial OfficerS - Sale$0.98-3,420286,173-1%-$3,364
2022-08-22
ARDXRosenbaum David P.Chief Development OfficerS - Sale$0.98-1,955469,4190%-$1,923
2022-08-22
ARDXBlanks RobertSee RemarksS - Sale$0.98-1,458317,6690%-$1,434
2022-08-22
ARDXRaab MichaelPres, CEOS - Sale$0.98-6,146688,044-1%-$6,045
2022-08-22
ARDXGrammer Elizabeth ASee RemarksS - Sale$0.98-1,236256,0810%-$1,216
2022-08-22
ARDXWilliams Laura AChief Medical OfficerS - Sale$0.98-1,276242,441-1%-$1,255
2022-08-22
ARDXRenz Justin ACFOS - Sale$0.98-1,498260,549-1%-$1,474
2022-07-26
ARDXBlanks RobertSee RemarksS - Sale$0.67-5,188319,127-2%-$3,476
2022-06-06
ARDXRenz Justin ACFOS - Sale$0.65-73,312262,047-22%-$47,696
2022-06-06
ARDXRodriguez SusanChief Commercial OfficerS - Sale$0.65-43,920289,593-13%-$28,574
2022-06-06
ARDXBlanks RobertSee RemarksS - Sale$0.65-73,312324,315-18%-$47,696
2022-06-06
ARDXGrammer Elizabeth ASee RemarksS - Sale$0.65-60,821257,317-19%-$39,569
2022-06-06
ARDXRosenbaum David P.Chief Development OfficerS - Sale$0.65-61,640471,374-12%-$40,102
2022-06-06
ARDXRaab MichaelPres, CEOS - Sale$0.65-103,624694,190-13%-$67,416
2022-05-20
ARDXRosenbaum David P.Chief Development OfficerS - Sale$0.67-2,013533,0140%-$1,352
2022-05-20
ARDXRenz Justin ACFOS - Sale$0.67-1,528335,3590%-$1,026
2022-05-20
ARDXRodriguez SusanChief Commercial OfficerS - Sale$0.67-3,425333,513-1%-$2,300
2022-05-20
ARDXBlanks RobertSee RemarksS - Sale$0.67-1,489397,6270%-$1,000
2022-05-20
ARDXRaab MichaelPres, CEOS - Sale$0.67-6,124797,814-1%-$4,112
2022-05-20
ARDXGrammer Elizabeth ASee RemarksS - Sale$0.67-1,263318,1380%-$848
2022-02-22
ARDXBlanks RobertSee RemarksS - Sale$0.67-1,752399,1160%-$1,174
2022-02-22
ARDXRaab MichaelPres, CEOS - Sale$0.67-6,229800,938-1%-$4,173
2022-02-22
ARDXRosenbaum David P.Chief Development OfficerS - Sale$0.67-2,353532,0270%-$1,577
2022-02-22
ARDXRodriguez SusanChief Commercial OfficerS - Sale$0.67-3,400333,938-1%-$2,278
M
2021-12-09
ARDXSandell Scott D10%S - Sale$1.26-2,881,57010,752,106-21%-$3,642,572
M
2021-12-09
ARDXBaskett Forest10%S - Sale$1.26-2,881,57010,752,012-21%-$3,642,572
2021-11-22
ARDXRosenbaum David P.Chief Development OfficerS - Sale$0.99-827479,3800%-$820
2021-11-22
ARDXRodriguez SusanChief Commercial OfficerS - Sale$0.99-643197,0300%-$638
2021-11-22
ARDXRenz Justin ACFOS - Sale$0.99-643293,6870%-$638
2021-11-22
ARDXRaab MichaelPres, CEOS - Sale$0.99-2,607657,1670%-$2,586
2021-11-22
ARDXJacobs Jeffrey WChief Scientific OfficerS - Sale$0.98-5,754119,483-5%-$5,629
2021-11-22
ARDXBlanks RobertSee RemarksS - Sale$0.99-643360,8680%-$638
2021-11-22
ARDXGrammer Elizabeth ASee RemarksS - Sale$0.99-537278,9290%-$533
2021-11-15
ARDXJacobs Jeffrey WChief Scientific OfficerS - Sale$1.13-5,000125,237-4%-$5,650
2021-11-12
ARDXGrammer Elizabeth ASee RemarksS - Sale$1.13-77,432279,466-22%-$87,111
2021-11-08
ARDXJacobs Jeffrey WChief Scientific OfficerS - Sale$1.18-2,166130,237-2%-$2,556

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top